Format

Send to:

Choose Destination
See comment in PubMed Commons below
Expert Rev Mol Med. 2008 Mar 28;10:e9. doi: 10.1017/S1462399408000628.

Molecular pathogenesis of intrahepatic cholestasis of pregnancy.

Author information

  • 1Department of Gastroenterology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile. marrese@med.puc.cl

Abstract

Intrahepatic cholestasis of pregnancy (ICP) occurs mainly in the third trimester and is characterised by pruritus and elevated serum bile acid levels. ICP is associated with an increased perinatal risk and higher rates of foetal morbidity and mortality. Although the pathogenesis of this disease is unknown, a genetic hypersensitivity to female hormones (oestrogen and/or progesterone) or their metabolites is thought to impair bile secretory function. Recent data suggest that mutations or polymorphisms of genes expressing hepatobiliary transport proteins or their nuclear regulators may contribute to the development and/or severity of ICP. Unidentified environmental factors may also influence pathogenesis of the disease. This review summarises current knowledge on the potential mechanisms involved in ICP at the molecular level.

PMID:
18371245
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Cambridge University Press
    Loading ...
    Write to the Help Desk